Skip to main content
. 2016 Jul 18;26(3):325–337. doi: 10.1017/S2045796016000305

Table 1.

Demographic characteristics of 1049SHIP participants with schizophrenia or schizo-affective disorder who reported using any antipsychotic medication in the past 4 weeks, by use of clozapine

Clozapine
No Yes
n % n % Adjusted OR 95% CI
Gender
Male 516 65.2 189 73.5 1.312 0.951–1.809
Female 276 34.8 68 26.5 1.0
Country of birth
Australia 640 80.8 227 88.3 1.077 0.737–1.574
Other 152 19.2 30 11.7 1.0
Marital status
Single, never married 518 65.4 203 79.0 2.197*** 1.397–3.455
Partnered 117 14.8 28 10.9 1.592 0.879–2.833
Separated, divorced, or widowed 157 19.8 26 10.1 1.0
Post school qualification 352 44.4 107 41.6 0.977 0.706–1.262
Paid employment (last 12 months) 233 29.4 67 26.1 0.929 0.699–1.289
Any homelessness (last 12 months) 108 13.6 17 6.6 0.408*** 0.238–0.701
Satisfaction with life (last 12 months)
Mostly satisfied or better 390 49.7 154 60.4 0.980 0.652–1.474
Mixed 274 34.9 82 32.2 1.185 0.778–1.804
Mostly dissatisfied or worse 121 15.4 19 7.5 1.0
Age 792 37.69 (11.23) 257 37.40 (9.51) 0.998 0.985–1.011
Age at Onset 792 23.98 (8.27) 257 22.26 (6.49) 0.950*** 0.989–0.970

SHIP, survey of high impact psychosis; OR, odds ratio; CI, confidence interval.

Satisfaction with life = 9 missing cases.

All variables are adjusted for chronicity and diagnosis.

Mean and (s.d.).

*p < 0.05, **p < 0.01, and ***p < 0.001.